1. Scheiber MD, Chen, SH, A Prospective Multi-center Registry of Patients Undergoing Hysteroscopic Morcellation of Uterine Polyps and Myomas. Journal of Gynecologic Surgery. 2016; ahead of print.
Use the right device for the right procedure. The device you choose is just one part of the complete MyoSure system. The full suite of MyoSure devices gives you a solution for tissue removal in a wide range of sizes and locations.
Remove targeted intrauterine tissue—while preserving uterine form and function.
Hologic is here to help guide you through the process of preparing your office to perform the MyoSure procedure, providing the comprehensive support you need to deliver the procedure.
We have compiled helpful information and tools to assist you in identifying, treating and reaching those patients who are candidates for the MyoSure procedure.
IMPORTANT SAFETY INFORMATION
The MyoSure® tissue removal system, consisting of the MyoSure tissue removal devices (LITE, REACH, XL) and MyoSure controller, is intended for hysteroscopic intrauterine procedures by trained gynecologists to resect and remove tissue including submucous myomas, endometrial polyps, and retained products of conception. The MyoSure MANUAL tissue removal device is intended for intrauterine use by a trained gynecologist to hysteroscopically resect and remove tissue, including focal lesions such as endometrial polyps and retained products of conception. MyoSure products are not appropriate for patients who are or may be pregnant, or are exhibiting pelvic infection, cervical malignancies, or previously diagnosed uterine cancer.
For more details on risks and benefits of the MyoSure system, MyoSure MANUAL tissue removal device, MyoSure hysteroscope and the Aquilex® fluid control system please see their respective IFUs.
© 2018 Hologic, Inc. All Rights Reserved